NEWMarkets
Ensysce Biosciences (ENSC) Director Resigns From Board
Published on 4/3/2026

AI Summary
Ensysce Biosciences (ENSC) announced the resignation of director Curtis Rosebraugh from its board. This departure could result in a shift in corporate governance and strategy. The company did not provide specific reasons for the resignation or any immediate impact on operations. The resignation of a board member can affect investor confidence and market perception of the company’s leadership.
Related News

Markets
Photronics (PLAB) SVP Wang Hsueh-Chun Sells $420,831 in Stock
Apr 3

Markets
Twin Vee PowerCats (VEEE) Receives Nasdaq Delisting Notice for Price
Apr 3

Markets
United Airlines (UAL) Raises Checked Bag Fees by $10-50 Due to Fuel Costs
Apr 3

Markets
Kratos (KTOS) Director Sells $2.17 Million in Company Stock
Apr 3